Jupiter Neurosciences amends SEPA with Yorkville, correcting outstanding shares to 34.3M and Exchange Cap to 6.86M

JUPITER NEUROSCIENCES, INC.

Corrects outstanding shares as of October 24, 2025 from 34,833,083 to 34,294,446.
Corrects Exchange Cap (max shares issuable without stockholder approval) from 7,180,504 to 6,855,459.
SEPA with Yorkville allows up to $20M stock sales; Yorkville advanced $3.72M for first convertible note (principal $4M, 7% OID).
Stockholder meeting scheduled for December 19, 2025 to seek approval to exceed Exchange Cap for additional issuances.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.